Waycross Partners’s CME Group CME Stock Holding History

Waycross Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$397K	Hold	1,344	–	–	0.04%	60
2025 Q4	$367K	Hold	1,344	–	–	0.03%	78
2025 Q3	$363K	Hold	1,344	–	–	0.03%	81
2025 Q2	$370K	Buy	+1,344	New	+$365K	0.03%	75

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Waycross Partners's CME Position: Q1 2026 in Review

Waycross Partners held its CME Group (CME) position steady in Q1 2026 at 1,344 shares worth $397K. The position accounts for 0.04% of the portfolio, ranked #60.

Waycross Partners first reported a position in CME in Q2 2025 and has held it in 4 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Waycross Partners held 1,344 shares of CME Group worth $397K as of Q1 2026.
Waycross Partners left its CME Group share count unchanged in Q1 2026.
CME Group made up 0.04% of Waycross Partners's portfolio in Q1 2026, its #60 holding.
Waycross Partners first reported a position in CME Group in Q2 2025 and has held it in 4 quarters since.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Waycross Partners's 13F filing for Q1 2026, filed 7 May 2026.